- Home
- PVL vs DTIL Comparison
PVL vs DTIL Comparison
Compare PVL & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PVL
- DTIL
- Stock Information
- Founded
- PVL 2011
- DTIL 2006
- Country
- PVL United States
- DTIL United States
- Employees
- PVL N/A
- DTIL N/A
- Industry
- PVL Oil & Gas Production
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- PVL Energy
- DTIL Health Care
- Exchange
- PVL Nasdaq
- DTIL Nasdaq
- Market Cap
- PVL 59.7M
- DTIL 55.3M
- IPO Year
- PVL N/A
- DTIL 2019
- Fundamental
- Price
- PVL $1.77
- DTIL $5.63
- Analyst Decision
- PVL
- DTIL Strong Buy
- Analyst Count
- PVL 0
- DTIL 2
- Target Price
- PVL N/A
- DTIL $47.00
- AVG Volume (30 Days)
- PVL 79.7K
- DTIL 97.9K
- Earning Date
- PVL 01-01-0001
- DTIL 11-03-2025
- Dividend Yield
- PVL 10.88%
- DTIL N/A
- EPS Growth
- PVL N/A
- DTIL N/A
- EPS
- PVL 0.09
- DTIL N/A
- Revenue
- PVL $4,598,992.00
- DTIL $1,261,000.00
- Revenue This Year
- PVL N/A
- DTIL N/A
- Revenue Next Year
- PVL N/A
- DTIL $135.19
- P/E Ratio
- PVL $19.03
- DTIL N/A
- Revenue Growth
- PVL 37.78
- DTIL N/A
- 52 Week Low
- PVL $1.30
- DTIL $3.61
- 52 Week High
- PVL $2.04
- DTIL $9.55
- Technical
- Relative Strength Index (RSI)
- PVL 35.41
- DTIL 67.19
- Support Level
- PVL $1.81
- DTIL $5.26
- Resistance Level
- PVL $1.84
- DTIL $5.55
- Average True Range (ATR)
- PVL 0.06
- DTIL 0.22
- MACD
- PVL -0.02
- DTIL 0.07
- Stochastic Oscillator
- PVL 1.79
- DTIL 88.89
About PVL Permianville Royalty Trust Trust Units
Permianville Royalty Trust is a statutory trust which holds net profits interests in the profits from the sale of oil and natural gas production from non-operated assets of both conventional properties in the States of Texas, Louisiana, and New Mexico as well as unconventional assets in the Permian and Haynesville basins.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.